Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

A NYC dermatologist is now offering brain treatments with an Exomind device, which is said to be a high-tech fix for ...

Dr. Jacqueline Libby explains why her team’s prototype soft exosuits could replace traditional, clunky stroke rehabilitation ...

Regenxbio is ranked Strong Buy due to low EV, strong partnerships, royalty income, bullish trends, and buyout potential.

After being diagnosed with Parkinson’s disease at just 50 years old, Tammy Corrigan turned to exercise to help manage her ...

The hiker and a companion had wandered off the remote 53-mile hiking path that follows the northern California coastline of ...

In the current dynamic world, where much of an organization’s decision-making is data-driven, companies from all sectors are faced with enormous challenges as they need to manage huge volumes of data ...

Equinox's GLP-1 protocol is considered a framework for people taking the drugs, one that addresses workout intensity, ...

This isn’t a typical analytical column for me or for our site; however, I’ve made it a point over the years to be transparent ...

To honor their journeys, we spoke with several Indigenous medical students who recently matched into physician-residency programs to learn more about what this moment means for them, their families, ...

Joining us today are Oncocyte President and CEO, Josh Riggs; Chief Science Officer, Ekke Schutz; and CFO, Andrea James. We ...

The Pittsburgh Steelers have been entangled in a quarterback saga surrounding Aaron Rodgers for a few weeks now. It started ...